Karl Hagler
Medical Oncology · Muscle Shoals, ALNPI 1891756805
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.5% of the total across 195 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 11.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,848 and has fallen 94.3% since, to $105 in 2024. That places this record below the midpoint for medical oncology clinicians in AL, where the typical reported total is $5,924.
Across 195 payments — averaging $15.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$360
- Novartis$305
- E.r. Squibb & Sons, L.L.C.$251
- Pfizer$208
- Amgen$201
- Exelixis Inc.$187
- plus $2K from 28 others
What the payments were for
- Speaking & faculty fees$1505%
- Food & beverage$2,81993%
- Education$783%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 14 | $360 |
| Novartis | 19 | $305 |
| E.r. Squibb & Sons, L.L.C. | 22 | $251 |
| Pfizer | 17 | $208 |
| Amgen | 15 | $201 |
| Exelixis Inc. | 9 | $187 |
| Bristol Myers Squibb | 13 | $186 |
| Incyte Corporation | 11 | $157 |
| Merck | 11 | $154 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $124 |
| Pharmacyclics LLC, An Abbvie Company | 7 | $115 |
| Johnson & Johnson | 6 | $111 |
| Eisai Inc. | 5 | $93 |
| Seagen Inc. | 6 | $90 |
| Genentech USA, Inc. | 5 | $84 |
| AbbVie | 2 | $48 |
| Daiichi Sankyo Inc. | 3 | $46 |
| Lilly USA, LLC | 3 | $42 |
| Array Biopharma Inc | 3 | $40 |
| Gilead | 2 | $28 |
| Taiho Oncology, Inc. | 2 | $25 |
| Puma Biotechnology, Inc. | 1 | $22 |
| Rigel Pharmaceuticals, Inc. | 1 | $16 |
| Karyopharm Therapeutics Inc. | 1 | $16 |
| Tesaro, Inc. | 1 | $15 |
| Springworks Therapeutics, Inc. | 1 | $15 |
| GSK | 1 | $15 |
| Astellas Pharma US Inc | 1 | $15 |
| Ipsen Biopharmaceuticals, Inc | 1 | $14 |
| Dova Pharmaceuticals | 1 | $13 |
| Kyowa Kirin, Inc. | 1 | $13 |
| Verastem, Inc. | 1 | $13 |
| Sun Pharmaceutical Industries Inc. | 1 | $12 |
| Heron Therapeutics, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ULTOMIRIS$150
How this compares
$3,047 in reported general payments places this provider in the 35th percentile of 30 medical oncology providers in Alabama.
Other medical oncology in Muscle Shoals
- Hemant PatelMuscle Shoals$3K
- Joelle HamiltonHomewood$361K
- Syed Abbas AliJasper$51K
- Pranitha ProdduturvarMobile$33K
- Johnny NacillaCullman$23K
- Michael GarciaJasper$23K
- John WaplesHuntsville$19K
- Susan BostickTuscaloosa$17K
- Brittany CaseDaphne$17K
- Charles LattuadaAnniston$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.